Jurgen Moll

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Efficacy and safety of mepolizumab in hypereosinophilic syndrome.

Efficacy and safety of mepolizumab in hypereosinophilic syndrome.

Journal: European annals of allergy and clinical immunology

Published: May 21, 2026

Combination of two novel blocking antibodies, anti-PD-1 antibody ezabenlimab (BI 754091) and anti-LAG-3 antibody BI 754111, leads to increased immune cell responses.

Combination of two novel blocking antibodies, anti-PD-1 antibody ezabenlimab (BI 754091) and anti-LAG-3 antibody BI 754111, leads to increased immune cell responses.

Journal: Oncoimmunology

Published: June 27, 2022

The descending pain modulation system predicts short term efficacy of multimodal pain therapy: an observational prospective cohort study.

The descending pain modulation system predicts short term efficacy of multimodal pain therapy: an observational prospective cohort study.

Journal: Postgraduate medicine

Published: December 13, 2021

BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition.

BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition.

Journal: Cancer discovery

Published: February 06, 2020

Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance.

Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance.

Journal: Molecular cancer therapeutics

Published: August 12, 2019

The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy.

The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy.

Journal: Molecular cancer therapeutics

Published: April 17, 2017

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.

Journal: Cell

Published: November 20, 2016

Spindle Misorientation of Cerebral and Cerebellar Progenitors Is a Mechanistic Cause of Megalencephaly.

Spindle Misorientation of Cerebral and Cerebellar Progenitors Is a Mechanistic Cause of Megalencephaly.

Journal: Stem cell reports

Published: June 29, 2016

Impaired Planar Germ Cell Division in the Testis, Caused by Dissociation of RHAMM from the Spindle, Results in Hypofertility and Seminoma.

Impaired Planar Germ Cell Division in the Testis, Caused by Dissociation of RHAMM from the Spindle, Results in Hypofertility and Seminoma.

Journal: Cancer research

Published: January 22, 2016

Cell Proliferation Method: Click Chemistry Based on BrdU Coupling for Multiplex Antibody Staining.

Cell Proliferation Method: Click Chemistry Based on BrdU Coupling for Multiplex Antibody Staining.

Journal: Current protocols in cytometry

Published: April 02, 2015

RHAMM deficiency disrupts folliculogenesis resulting in female hypofertility.

RHAMM deficiency disrupts folliculogenesis resulting in female hypofertility.

Journal: Biology open

Published: March 10, 2015

Efficacy and mechanism of action of volasertib, a potent and selective inhibitor of Polo-like kinases, in preclinical models of acute myeloid leukemia.

Efficacy and mechanism of action of volasertib, a potent and selective inhibitor of Polo-like kinases, in preclinical models of acute myeloid leukemia.

Journal: The Journal of pharmacology and experimental therapeutics

Published: January 11, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026